(Q35629114)

English

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

scientific article published on January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines (English)

1 reference

Europe PubMed Central

9 August 2017

attenuated vaccine

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

Karl Albert Brokstad

2

object named as

Brokstad KA

1 reference

Europe PubMed Central

9 August 2017

author name string

Cox RJ

1

1 reference

Europe PubMed Central

9 August 2017

Ogra P

3

1 reference

Europe PubMed Central

9 August 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

9 August 2017

Scandinavian Journal of Immunology

1 reference

Europe PubMed Central

9 August 2017

59

1 reference

Europe PubMed Central

9 August 2017

1-15

1 reference

Europe PubMed Central

9 August 2017

1

1 reference

Europe PubMed Central

9 August 2017

Initial genetic characterization of the 1918 "Spanish" influenza virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Influenza virus infections in infants

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Influenza-related hospitalizations among children in Hong Kong.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Temperature-Sensitive Mutants of Influenza Virus. III. Further Characterization of the ts-1[E] Influenza A Recombinant (H3N2) Virus in Man

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

High prevalence of influenza specific antibody secreting cells in nasal mucosa

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Immunity to influenza in man

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Parameters of humoral and cellular immunity of influenza A/USSR/90/77 (H1N1) virus in various age groups

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Clinical practice. Influenza vaccination for healthy young adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Safety and immunogenicity of a paediatric presentation of an influenza vaccine

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

IgA, IgA subclasses, and secretory component levels in oral fluid collected from subjects after parental influenza vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Lymphocyte distribution in the tonsils prior to and after influenza vaccination.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

The effect of zanamivir treatment on the early immune response to influenza vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Vaccination strategies for mucosal immune responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Live attenuated vaccines against influenza; an historical review

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Live attenuated influenza virus vaccines: new options for the prevention of influenza

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

The impact of influenza in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Influenza vaccines: present and future

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

IDENTIFICATION OF THE ANTIVIRAL SUBSTANCES IN NASAL SECRETIONS

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Immune response of the human respiratory tract. II. Cell-mediated immunity in the lower respiratory tract to tuberculin and mumps and influenza viruses

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Rapid immune response to influenza vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Summary of Clinical Trials of Inactivated Influenza Vaccine--1978

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Parenteral influenza vaccination induces a rapid systemic and local immune response

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Cross-reaction but no avidity change of the serum antibody response after influenza vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Systemic and local immune responses after parenteral influenza vaccination in juvenile diabetic patients and healthy controls: results from a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Intranasal, cold-adapted, live, attenuated influenza vaccine

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist, administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01382.X

21 January 2018

Identifiers

10.1111/J.0300-9475.2004.01382.X

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35629114&oldid=1582784798"